UBS Group’s Adagio Medical Holdings ADGM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.48K Buy
+2,268
New +$2.22K ﹤0.01% 9542
2025
Q4
Sell
-83
Closed -$161 11361
2025
Q3
$161 Sell
83
-12,476
-99% -$19.4K ﹤0.01% 9857
2025
Q2
$16.3K Buy
+12,559
New +$14.3K ﹤0.01% 8575
2025
Q1
Sell
-1,409
Closed -$1.48K 10867
2024
Q4
$1.48K Buy
1,409
+1,118
+384% +$2.7K ﹤0.01% 9225
2024
Q3
$751 Buy
+291
New +$1.39K ﹤0.01% 8832

Other funds holding ADGM

UBS Group's ADGM Position: Q2 2026 in Review

UBS Group opened a new position in Adagio Medical Holdings (ADGM) in Q2 2026: 2,268 shares worth $1.48K. The stake represents ﹤0.01% of the portfolio and ranks #9542 among its holdings. This is a return to the name: UBS Group previously reported a position in ADGM as recently as Q3 2025.

UBS Group first reported a position in ADGM in Q3 2024 and has held it in 5 quarters since. The position peaked at $16.3K in Q2 2025. 24 funds tracked by Wall St. Rank hold ADGM as of Q2 2026.

  • UBS Group held 2,268 shares of Adagio Medical Holdings worth $1.48K as of Q2 2026.
  • Adagio Medical Holdings was a new UBS Group position in Q2 2026.
  • Adagio Medical Holdings made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #9542 holding.
  • UBS Group first reported a position in Adagio Medical Holdings in Q3 2024 and has held it in 5 quarters since.
  • UBS Group's Adagio Medical Holdings position peaked at $16.3K in Q2 2025.
  • 24 funds tracked by Wall St. Rank held Adagio Medical Holdings as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.